Yao Wang

11.5k total citations · 2 hit papers
217 papers, 8.4k citations indexed

About

Yao Wang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Yao Wang has authored 217 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Oncology, 57 papers in Molecular Biology and 50 papers in Immunology. Recurrent topics in Yao Wang's work include CAR-T cell therapy research (59 papers), Immune Cell Function and Interaction (33 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Yao Wang is often cited by papers focused on CAR-T cell therapy research (59 papers), Immune Cell Function and Interaction (33 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Yao Wang collaborates with scholars based in China, United States and Australia. Yao Wang's co-authors include Weidong Han, Hanren Dai, Yelei Guo, George A.C. Murrell, Timothy J. Molloy, Zhiqiang Wu, Kaichao Feng, Qingming Yang, Chuan Tong and Meixia Chen and has published in prestigious journals such as Science, The Lancet and Nucleic Acids Research.

In The Last Decade

Yao Wang

207 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells

2020 940 citations Yao Wang, Weidong Han et al. profile →
The Roles of Growth Factors in Tendon and Ligament Healing

2003 727 citations Yao Wang et al. profile →

Peers

Countries citing papers authored by Yao Wang

Since Specialization

Citations

This map shows the geographic impact of Yao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yao Wang more than expected).

Fields of papers citing papers by Yao Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yao Wang. The network helps show where Yao Wang may publish in the future.

Co-authorship network of co-authors of Yao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yao Wang. A scholar is included among the top collaborators of Yao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yao Wang. Yao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DCR2-targeted ultrasound nanobubbles loaded with verteporfin promote M2 macrophage polarization to overcome doxorubicin resistance in breast cancer 2025 ·Chemical Engineering Journal ·Shuyue Guo, (unknown), Yao Wang, (unknown), Jialin Zhu, (unknown), Wenwu Ling, Kenneth D. Westover, Zhiwei Zhou, Xi Wei	1
2	CD2 augmentation enhances CAR-T-cell efficacy via immunological synapse remodeling and T-cell exhaustion mitigation 2025 ·Cellular and Molecular Immunology ·(unknown), (unknown), (unknown), Lu Han, Zhiqiang Wu, Yao Wang, Xin Lin, Jianshu Wei, Weidong Han	1
3	In Situ Bioorthogonal Repair of the Vascular Endothelium Glycocalyx to Treat Acute Lung Injury 2024 ·Small ·Yao Wang, (unknown), (unknown), Weidong Li, Anqi Wang, Zhoujiang Chen, Huile Gao, Di Wu, Fang Geng, Daniel Scherman, Xianwen Wang, Sanjun Shi, Liang Zou, Hanmei Li	2
4	Tumor-draining lymph nodes: opportunities, challenges, and future directions in colorectal cancer immunotherapy 2024 ·Journal for ImmunoTherapy of Cancer ·Yao Wang, Tingting Zhu, Qi Shi, Guanghui Zhu, Siwei Zhu, Fenggang Hou	11
5	Silencing Rac1 and Prex1 Inhibit Epithelial–Mesenchymal Transition in Human Gastric Cancer Cells Induced by Transforming Growth Factor-β1 2023 ·The Turkish Journal of Gastroenterology ·(unknown), Xiaoyan Lin, (unknown), (unknown), Yao Wang, (unknown), Junde Li, (unknown), (unknown)	2
6	Dahuang zhechong pill ameliorates hepatic fibrosis by regulating gut microbiota and metabolites 2023 ·Journal of Ethnopharmacology ·Xiao-yan He, Jingtao Liang, Xin Li, Yao Wang, Xiaobo Zhang, Dayi Chen, Lijuan Wu, Shiyu Wang	10
7	Fabrication of Bi/BiOCOOH/PVDF with improved photocatalytic activity for the degradation of ciprofloxacin 2023 ·Surfaces and Interfaces ·(unknown), Haoyang Xu, (unknown), Yao Wang, Liang Zhang, Zhiqiang Zhang, Lvling Zhong, (unknown)	14
8	Synergistic activity and mechanism of cytarabine and MCL-1 inhibitor AZD5991 against acute myeloid leukemia 2023 ·Neoplasma ·Yue Wang, (unknown), Yao Wang, (unknown), Guan Wang, (unknown)	5
9	Laminin β4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid 2023 ·Journal of the American Academy of Dermatology ·Stephanie Goletz, Manuela Pigors, (unknown), Christoph M. Hammers, Yao Wang, Shirin Emtenani, Monique Aumailley, Maike M. Holtsche, Felix Stang, Imke Weyers, Inke R. König, Cristina Has, (unknown), Lars Komorowski, Detlef Zillikens, Enno Schmidt	13
10	Case report: Immune modulation after PD-1 inhibitor therapy in a patient with extranodal NK/T-cell lymphoma secondary to chronic active Epstein-Barr virus disease unveiled by single-cell transcriptomics 2023 ·Frontiers in Immunology ·Yao Wang, (unknown), (unknown), Huan‐Xiang Zhou, Jie Chen, Hong Wang, Yaping Zhang, Wenyu Shi	1
11	Efficacy of Chinese herbal medicine on poststroke depression in animal models: A systematic review and meta-analysis 2023 ·Frontiers in Neurology ·Li Li, (unknown), Yuan Wang, Yao Wang, Ying Gong, (unknown), Tingting Liu, (unknown), (unknown)	4
12	The net electrostatic potential and hydration of ABCG2 affect substrate transport 2023 ·Nature Communications ·(unknown), Heather M. Aitken, Yao Wang, J.A. Lynch, Evadnie Rampersaud, Yu Fukuda, (unknown), Stefanie A. Baril, Robert C. Ford, Anang A. Shelat, (unknown), John D. Schuetz	8
13	[Clinical Observation of Venetoclax Combined with Demethylating Agents on the Treatment of Relapsed/Refractory Acute Myeloid Leukemia]. 2023 ·PubMed ·Yao Wang, (unknown), Xingxia Zhang, (unknown), Guo‐Qiang Lin, (unknown), Bing Zhang, Yan Wan, Li Wang, Yanming Zhang	0
14	IL-6 translation is a therapeutic target of human cytokine release syndrome 2023 ·The Journal of Experimental Medicine ·Yuzhuo Yang, (unknown), (unknown), (unknown), Xin Lin, Yao Wang, (unknown), Chunmeng Wang, Bin Zhang, Weidong Han, Xiaoyu Hu	14
15	Long-term activity of tandem CD19/CD20 CAR therapy in refractory/relapsed B-cell lymphoma: a single-arm, phase 1–2 trial 2021 ·Leukemia ·(unknown), Yao Wang, Yang Liu, Chuan Tong, Chunmeng Wang, Yelei Guo, Dongdong Ti, Qingming Yang, (unknown), Zhiqiang Wu, Weidong Han	64
16	Interaction Between Susceptibility Loci in MAVS and TRAF3 Genes, and High-risk HPV Infection on the Risk of Cervical Precancerous Lesions in Chinese Population 2018 ·Cancer Prevention Research ·Di Xiao, Dandan Liu, Zihao Wen, (unknown), Chengli Zeng, Zixing Zhou, Yajing Han, Xiaohong Ye, (unknown), Yao Wang, Congcong Guo, Meiling Ou, Shiqi Huang, (unknown), Xiangcai Wei, Guang Yang, Chunxia Jing	3
17	Restoration of CD3+CD56+ cell level improves skin lesions in severe psoriasis: A pilot clinical study of adoptive immunotherapy for patients with psoriasis using autologous cytokine-induced killer cells 2018 ·Cytotherapy ·Hanren Dai, (unknown), Chuan Tong, Yelei Guo, Fengxia Shi, Yao Wang, Pingping Shen	5
18	Phase I Study of Chimeric Antigen Receptor–Modified T Cells in Patients with EGFR-Positive Advanced Biliary Tract Cancers 2017 ·Clinical Cancer Research ·Yelei Guo, Kaichao Feng, Yang Liu, Zhiqiang Wu, Hanren Dai, Qingming Yang, Yao Wang, Hejin Jia, Weidong Han	196
19	Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial 2016 ·Clinical Cancer Research ·Chunmeng Wang, Zhiqiang Wu, Yao Wang, Yelei Guo, Hanren Dai, Xiaohui Wang, Xiang Li, (unknown), Wenying Zhang, Meixia Chen, Yan Zhang, Kaichao Feng, Yang Liu, Su‐Xia Li, Qingming Yang, Weidong Han	261
20	EpCAM-Regulated Transcription Exerts Influences on Nanomechanical Properties of Endometrial Cancer Cells That Promote Epithelial-to-Mesenchymal Transition 2016 ·Cancer Research ·Ya‐Ting Hsu, Paweł A. Osmulski, Yao Wang, Yi-Wen Huang, Lu Liu, Jianhua Ruan, Victor X. Jin, Nameer B. Kirma, Maria Gaczyńska, (unknown)	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact